Dow Jones received a payment from EQS/DGAP to publish this press release.
DGAP-Media / 2018-07-12 / 16:06
*Carl Zeiss Meditec AG *
*Carl Zeiss Meditec AG Announces New CFO and Expansion of the
Management Board*
*Effective 1 October 2018, Dr. Christian Müller, current CFO of
Carl Zeiss Meditec AG, will become CFO of Carl Zeiss AG
Justus Felix Wehmer to become new CFO of Carl Zeiss Meditec AG
Management Board of Carl Zeiss Meditec AG to be expanded with
appointment of Jan Willem de Cler*
JENA, July 12, 2018.
Effective 30 September 2018, Dr. Christian Müller will leave the Management
Board of Carl Zeiss Meditec AG (FSE: AFX) and, on 1 October 2018, will
become Chief Financial Officer (CFO) of Carl Zeiss AG. Müller has served as
CFO of Carl Zeiss Meditec AG since 2009. He came to Carl Zeiss Meditec AG in
2006 where he headed the newly created Surgical Ophthalmology strategic
business unit. The Supervisory Board of Carl Zeiss Meditec AG has appointed
Justus Felix Wehmer as CFO of Carl Zeiss Meditec AG, also effective 1
October 2018. Mr. Wehmer is currently CFO and Co-Head of the ZEISS
Microscopy business group.
In addition, effective 1 October 2018, the Management Board of Carl Zeiss
Meditec AG will be expanded from two to three members with the appointment
of Jan Willem de Cler. Mr. de Cler has been at ZEISS since 2004 and
currently heads Surgical Ophthalmology within Carl Zeiss Meditec AG. As
Member of the Management Board, his responsibilities will include Human
Resources and Employee Development.
"We are particularly pleased that we were able to appoint long-time
employees from the ZEISS Group to these positions. This will ensure that we
can continue driving our current strategy. The Supervisory Board would like
to thank Dr. Christian Müller for his excellent work over the past nine
years and wishes Mr. Wehmer and Mr. de Cler much success with their new
positions," said Prof. Dr. Michael Kaschke, Chairman of the Supervisory
Board of Carl Zeiss Meditec AG.
*Dr. Christian Müller* has been CFO and Member of the Management Board of
Carl Zeiss Meditec AG since 2009. He is responsible for Finance and
Controlling, Investor Relations, and Legal and Taxes. He also oversees
Service, Quality Management and Regulatory Affairs. Dr. Müller joined the
ZEISS Group in 2002 as Vice-President of Corporate Auditing and Risk
Management. In 2006, he transferred to Carl Zeiss Meditec AG where he headed
the newly created Surgical Ophthalmology strategic business unit with sites
in Germany, France and Scotland. He previously served as head of finance at
Degussa AG starting in 1999 and, from 1997, as department head for auditing
and risk management at VIAG AG. He began his professional career at the
auditing company C&L Deutsche Revision in 1992. Dr. Christian Müller holds a
degree in business administration and completed his Ph.D. at the University
of Frankfurt am Main in 1996.
*Justus Felix Wehmer* has served as Co-Head of the Microscopy business group
and Managing Director of Carl Zeiss Microscopy GmbH since 2015. He headed
Carl Zeiss Jena GmbH beginning in 2013. Prior to this, he was vice-president
of finance and strategy and general manager at NXP Semiconductors Germany
GmbH in Hamburg. He had already worked at ZEISS in the period from 2002 to
2012 - initially as Senior Vice-President for Finance at the Industrial
Metrology business group and, from 2007, he held the same position at the
Semiconductor Manufacturing Technology business group. Justus Felix Wehmer
studied business administration at the Academy of Business and
Administration in Essen and was awarded an MBA by the London Business School
in 1995.
*Jan Willem de Cler* has been Head of Surgical Ophthalmology at Carl Zeiss
Meditec AG since 2010. He came to ZEISS in 2004 as Managing Director of the
Benelux sales and service company. He also served as Managing Director of
the sales and service company in France and of France Chirurgie
Instrumentation (FCI). In January 2014, he was responsible for the strategic
acquisition of the American company Aaren Scientific Inc., which enabled the
further globalization of the surgical ophthalmology business. Jan Willem de
Cler studied marketing and management at Nijenrode University in the
Netherlands and earned an MBA in international business from the University
of Oregon, USA. After holding different positions at General Electric and GE
Medical Systems, he became co-founder and head of sales & marketing for the
startup Global Healthcare Exchange Europe.
*Contact for investors and press *
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone:+493641 220-116
Email: investors.meditec@.zeiss.com
*www.zeiss.com/press [1]*
End of Media Release
Issuer: Carl Zeiss Meditec AG
Key word(s): Enterprise
2018-07-12 Dissemination of a Press Release, transmitted by DGAP - a service
of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: investors.meditec@zeiss.com
Internet: www.zeiss.de/meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich,
Stuttgart, Tradegate Exchange
End of News DGAP Media
704041 2018-07-12
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=09338a162e7cecd74418a8b37dc606c5&application_id=704041&site_id=vwd&application_name=news
(END) Dow Jones Newswires
July 12, 2018 10:06 ET (14:06 GMT)
